A hidden mark of a troubled past: neuroimaging and transcriptomic analyses reveal interactive effects of maternal immune activation and adolescent THC exposure in the absence of overt behavioural disruptions

Maternal exposure to infections during gestation has been shown to predispose individuals to the development of schizophrenia. Additionally, clinical data suggest that cannabis use could trigger the onset of schizophrenia in vulnerable individuals. However, the direction of causality remains unclear. To elucidate this issue, we utilised a rat model of maternal immune activation, combined with exposure to increasing doses of THC during adolescence, in both male and female rats. We investigated several behaviours in adulthood that resemble specific symptoms of schizophrenia, including impairments in working memory, deficits in sensorimotor gating, alterations in social behaviour, anhedonia, and potential changes in implicit learning (conditioned taste aversion). Furthermore, we conducted a longitudinal positron emission tomography (PET) study to identify affected brain regions and subsequently collected brain samples from one of these regions (the orbitofrontal cortex) for RNA sequencing analyses. These analyses were also performed on peripheral blood mononuclear cells to identify peripheral biomarkers. Notably, while no overt behavioural disruptions were observed, our PET scans revealed several brain alterations dependent on the combination of both exposures. Additionally, the transcriptomic studies demonstrated that maternal immune activation affected glutamatergic and serotoninergic genes, with the combination of both exposures shifting the expression from down-regulation to up-regulation. In peripheral cells, interactive effects were observed on inflammatory pathways, and some genes were proposed as biomarkers of the disease. These results suggest that the combination of these two vulnerability factors leaves a lasting mark on the body, potentially predisposing individuals to the disease even before behavioural alterations manifest.